In a recent safety announcement the U.S. Food and Drug Administration (FDA) alerted American consumers to a recall of two generic blood pressure medications manufactured…
Category: Dangerous Drugs & Devices
FDA to Require New Boxed Warning Label on Arthritis, Ulcerative Colitis Drugs Xeljanz® and Xeljanz XR®
In a September 1 announcement, the U.S. Food and Drug Administration (FDA) announced it will now be requiring an updated boxed warning label to be…
FDA Warns Health Care Providers to Stop Using Stainless Steel NuVasive Precice® Limb-Lengthening Devices
In a recent letter to health care providers, the U.S. Food and Drug Administration (FDA) expressed its concern over NuVasive Specialized Orthopedics, Inc.'s Precice® devices…
3M Loses First Trial over Allegedly Defective Military Earplugs in a 7.1M Verdict
A Florida federal jury has hit manufacturer 3M with a $7.1 Million verdict in the first bellwether trial of a multidistrict litigation hearing involving 3M's…
Peloton® Faces Questions about Dangers to Children After Death and Serious Injuries
A child's death by injuries from a Peloton® Tread+™ has led the U.S. Consumer Product Safety Commission (CPSC) to warn against using the popular at-home…
This Parkinson’s Awareness Month Learn About Paraquat — One of the Disease’s Environmental Triggers
April marks Parkinson’s Awareness Month. Established by the Parkinson’s Foundation, the month-long observation aims to raise broader awareness of Parkinson’s disease, some of its potential…
Is Paragard® Dangerous? Here's What To Know
Paragard® is a copper intrauterine device (IUD) used by thousands of American women to provide long-term birth control. It is one of five available IUDs…
Study: Popular PPI Heartburn Medications Increase Risk for COVID-19 Complications
As many as 15 million Americans routinely treat heartburn with prescriptions for popular over-the-counter medications like Prilosec®, Nexium®, and Prevacid®. The number of Americans who…
Used to Treat Age-Related Macular Degeneration, Beovu® May Cause More Vision Problems Than It Solves
Relatively new to the drug market, Beovu® (brolucizumab) was approved by the U.S. Food and Drug Administration (FDA) in 2019 to treat age-related macular degeneration,…
